AI model flags chronic stress signal in routine CT scans

Researchers have developed a deep learning model that estimates chronic stress burden by measuring adrenal gland volume on standard CT scans, introducing what they describe as the first imaging-based biomarker for chronic stress. The metric, called the Adrenal Volume Index, is linked to cortisol exposure, perceived stress, overall physiological stress load and long-term cardiovascular risk, according to findings to be presented at the Radiological Society of North America's annual meeting.

Chronic stress can profoundly affect health, contributing to problems such as anxiety, trouble sleeping, muscle pain, high blood pressure, a less effective immune system, and major conditions including heart disease, depression and obesity, according to the American Psychological Association.

A new study led by Elena Ghotbi, M.D., a postdoctoral research fellow at Johns Hopkins University School of Medicine in Baltimore, Maryland, proposes a way to visualize the long-term impact of stress using CT scans that patients already receive for other reasons.

According to a report from the Radiological Society of North America (RSNA), Ghotbi and colleagues trained a deep learning artificial intelligence tool to automatically measure adrenal gland size on routine chest CT images. Each year, tens of millions of chest CT scans are performed in the United States alone.

From these measurements, the team derived a metric they call the Adrenal Volume Index (AVI), defined as adrenal volume in cubic centimeters divided by height squared in meters (cm³/m²). The researchers describe AVI as an imaging marker that reflects chronic stress burden, in contrast to single time-point cortisol tests that capture hormone levels only at the moment of sampling.

The study used data from the Multi-Ethnic Study of Atherosclerosis (MESA) and included adults who had undergone chest CT imaging as well as detailed stress-related assessments. RSNA's summary reports that the team linked AI-derived AVI to cortisol measurements, allostatic load (a composite measure that can include factors such as body mass index, blood pressure and glucose levels) and psychosocial indicators like perceived stress and depression scores.

Higher AVI values were associated with greater overall cortisol exposure, higher peak cortisol levels and increased allostatic load. Participants who reported higher levels of perceived stress had higher AVI than those reporting lower stress. The researchers also found that AVI was related to a higher left ventricular mass index, a measure of heart structure, and that for every 1 cm³/m² increase in AVI, the risk of heart failure and death rose over follow-up of up to 10 years, according to the RSNA summary.

"Our approach leverages widely available imaging data and opens the door to large-scale evaluations of the biological impact of chronic stress across a range of conditions using existing chest CT scans," Ghotbi said in remarks released by RSNA.

Senior author Shadpour Demehri, M.D., a professor of radiology at Johns Hopkins, said the technique allows clinicians to visualize the long-term burden of stress inside the body using a scan that many patients already undergo as part of routine care.

In the RSNA report, co-author Teresa E. Seeman, Ph.D., professor of epidemiology at UCLA, said the work is especially notable because it links a routinely obtained imaging feature—adrenal volume—with validated biological and psychological measures of stress and demonstrates that it independently predicts a major clinical outcome.

The researchers say this imaging biomarker could potentially refine cardiovascular risk assessment and preventive strategies without additional radiation exposure or extra testing, and that it may be relevant across a range of stress-related diseases that commonly affect middle-aged and older adults.

Other contributors listed in the RSNA summary include Roham Hadidchi, Seyedhouman Seyedekrami, Quincy A. Hathaway, M.D., Ph.D., Michael Bancks, Nikhil Subhas, Matthew J. Budoff, M.D., David A. Bluemke, M.D., Ph.D., R. Graham Barr and Joao A.C. Lima, M.D.

相关文章

AI interface analyzing back-of-hand and clenched-fist photos for acromegaly detection in Kobe University research, privacy-focused medical innovation.
AI 生成的图像

Kobe University team reports AI can flag acromegaly from privacy-conscious hand photos

由 AI 报道 AI 生成的图像 事实核查

Researchers in Japan say they have developed an artificial intelligence model that can help detect acromegaly by analyzing photos of the back of the hand and a clenched fist—an approach designed to avoid using facial images or fingerprints. The team reports the system performed well in testing and could help clinicians identify potential cases earlier and refer patients for specialist evaluation.

A large U.S. study has found that 27 percent of patients with resistant hypertension have hypercortisolism, an excess of the stress hormone cortisol. The MOMENTUM study, involving 1,086 participants across 50 centers, showed this condition is far more common than previously thought in those whose blood pressure remains high despite multiple medications. The discovery suggests screening for elevated cortisol could help explain treatment failures.

由 AI 报道

New research from the University of Southern California suggests that subtle declines in brain blood flow and oxygen delivery may be early indicators of Alzheimer's disease. The study, published in Alzheimer's and Dementia, used noninvasive scans to connect vascular health with amyloid plaques and hippocampal shrinkage. These findings highlight the role of brain circulation in the disease process beyond traditional markers like amyloid and tau.

Rice University scientists say they have created the first complete, label-free molecular atlas of an Alzheimer’s brain in an animal model, combining hyperspectral Raman imaging with machine learning to map chemical changes that appear unevenly across brain regions and extend beyond amyloid plaques.

此网站使用 cookie

我们使用 cookie 进行分析以改进我们的网站。阅读我们的 隐私政策 以获取更多信息。
拒绝